TSW
OME

Thompson Siegel & Walmsley’s Omega Protein OME Stock Holding History

Thompson Siegel & Walmsley’s Portfolio OME Stock Details OME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,300
Closed -$18K – 713
2014
Q2 		$18K Hold
1,300
– – ﹤0.01% 560
2014
Q1 		$16K Hold
1,300
– – ﹤0.01% 561
2013
Q4 		$16K Hold
1,300
– – ﹤0.01% 542
2013
Q3 		$13K Hold
1,300
– – ﹤0.01% 555
2013
Q2 		$12K Buy
+1,300
New +$13.1K ﹤0.01% 568

Other funds holding OME

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return

Thompson Siegel & Walmsley's OME Position: Q3 2014 in Review

Thompson Siegel & Walmsley sold out of Omega Protein (OME) in Q3 2014, closing a stake of 1,300 shares — an estimated $18K sold.

Thompson Siegel & Walmsley first reported a position in OME in Q2 2013 and held it in 5 quarters. The position peaked at $18K in Q2 2014. 131 funds tracked by Wall St. Rank hold OME as of Q3 2014.

  • Thompson Siegel & Walmsley reported no remaining Omega Protein position as of Q3 2014 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 1,300 Omega Protein shares in Q3 2014, an estimated $18K.
  • Thompson Siegel & Walmsley first reported a position in Omega Protein in Q2 2013 and held it in 5 quarters.
  • Thompson Siegel & Walmsley's Omega Protein position peaked at $18K in Q2 2014.
  • 131 funds tracked by Wall St. Rank held Omega Protein as of Q3 2014.

Based on Thompson Siegel & Walmsley's 13F filing for Q3 2014, filed 12 Nov 2014.